International environmental and sustainability consultancy Quantis has been purchased by Boston Consulting Group. The move comes as the strategy giant looks to bolster its sustainability credentials and aid clients with the transition to net zero.
Tags :Slider
The listed company Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into a senior secured loan agreement with funds managed by the US company Athyrium Capital Management. The CHF 75 million senior secured loan will be used
Baker McKenzie has acted for CLSA and other underwriters in connection with Joincare Pharmaceutical Group Industry, on global depositary receipts listing on the SIX Swiss Exchange. This transactions proves that the China-Switzerland Stock Connect has
Kellerhals Carrard has informed that Roman Huber has recently been elected as co-chair of the Swiss Ethics and Compliance Working Group (ECS). The Investigations Working Group is open to members of the ECS, as well
Stadtcasino Baden has acquisted a majority stake in Casinò Locarno. With this acquisition, the group extends its footprint to the Italian speaking part of Switzerland. Stadtcasino Baden and its subsidiaries are one of the largest
DKSH Holding has acquired Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its performance materials business unit platform to the US and Canada. The transaction is an
Niederer Kraft Frey advised the Beijing company Lepu Medical Technology on its successful USD 224 million offering and listing of global depositary receipts on SIX Swiss Exchange within the framework of the China-Switzerland Stock Connect
Schellenberg Wittmer has advised Asker Healthcare Group on its acquisition of all shares in the Swiss medical supplies distributor Aichele Medico from the founding family and the company’s management team. Asker Helathcare, headquartered in
CMS Switzerland has represented Diffulivre, a Swiss company and member of the Hachette Group, in an appeal before the Swiss Supreme Court brought against the judgment by the Swiss Administrative Court of 30 October 2019 concerning the
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio
